{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:42:52Z","timestamp":1792698172944,"version":"4.5.0"},"reference-count":105,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is a prevalent and challenging disease associated with a significant health and economic burden. MAFLD has been subjected to and widely investigated in many studies; however, the underlying pathogenesis and its progression have yet to understand fully. Furthermore, precise biomarkers for diagnosing and specific drugs for treatment are yet to be discovered. Increasing evidence has proven gut microbiota as the neglected endocrine organ that regulates homeostasis and immune response. Targeting gut microbiota is an essential strategy for metabolic diseases, including MAFLD. Gut microbiota in the gut-liver axis is connected through tight bidirectional links through the biliary tract, portal vein, and systemic circulation, producing gut microbiota metabolites. This review focuses on the specific correlation between gut microbiota metabolites and MAFLD. Gut microbiota metabolites are biologically active in the host and, through subsequent changes and biological activities, provide implications for MAFLD. Based on the review studies, gut-liver axis related-metabolites including short-chain fatty acids, bile acids (BAs), lipopolysaccharide, choline and its metabolites, indole and its derivates, branched-chain amino acids, and methionine cycle derivates was associated with MAFLD and could be promising MAFLD diagnosis biomarkers, as well as the targets for MAFLD new drug discovery.<\/jats:p>","DOI":"10.4103\/tcmj.tcmj_122_23","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T09:00:33Z","timestamp":1694163633000},"page":"290-299","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease"],"prefix":"10.4103","volume":"35","author":[{"given":"Rachmad Anres","family":"Dongoran","sequence":"first","affiliation":[{"name":"Indonesian Food and Drug Authority, Jakarta, Indonesia"},{"name":"Center for Chinese Studies, National Central Library, Taipei, Taiwan"},{"name":"Program in Asia Pacific Regional Studies, Department of Taiwan and Regional Studies, College of Humanities and Social Sciences, National Dong Hwa University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Cen","family":"Tu","sequence":"additional","affiliation":[{"name":"Program in Pharmacology and Toxicology, School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Hung","family":"Liu","sequence":"additional","affiliation":[{"name":"Program in Pharmacology and Toxicology, School of Medicine, Tzu Chi University, Hualien, Taiwan"},{"name":"Department of Pharmacology, School of Medicine, Tzu Chi University, Hualien, Taiwan"},{"name":"Graduate Institute of Clinical Pharmacy, School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease:An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD:A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.clinthera.2021.01.007","article-title":"Nonalcoholic fatty liver disease:A global perspective","volume":"43","author":"Wong","year":"2021","journal-title":"Clin Ther"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease \u2013A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC:Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease:Practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/me.2014-1108","article-title":"Minireview:Gut microbiota:The neglected endocrine organ","volume":"28","author":"Clarke","year":"2014","journal-title":"Mol Endocrinol"},{"issue":"Suppl 1","key":"R12-20240828","doi-asserted-by":"crossref","first-page":"e8537","DOI":"10.1002\/rcm.8537","article-title":"Measurement of gut microbial metabolites in cardiometabolic health and translational research","volume":"34","author":"Wu","year":"2020","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.3390\/ijms21175999","article-title":"Microbiota-associated therapy for non-alcoholic steatohepatitis-induced liver cancer:A review","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD:How is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide:A systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"115033","DOI":"10.1016\/j.bcp.2022.115033","article-title":"Methionine cycle in nonalcoholic fatty liver disease and its potential applications","volume":"200","author":"Wang","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence:From \u201ctwo hit theory\u201dto \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"R21-20240828","first-page":"1474","article-title":"The Firmicutes\/bacteroidetes ratio:A relevant marker of gut dysbiosis in obese patients?Nutrients","volume":"12","author":"Magne","year":"2020"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.14336\/AD.2022.0104","article-title":"Functions of gut microbiota metabolites, current status and future perspectives","volume":"13","author":"Liu","year":"2022","journal-title":"Aging Dis"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1007\/s00018-018-2901-1","article-title":"Implication of gut microbiota metabolites in cardiovascular and metabolic diseases","volume":"75","author":"Brial","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"R24-20240828","first-page":"180","article-title":"Postbiotics as the key mediators of the gut microbiota-host interactions","volume":"30","author":"Ozma","year":"2022","journal-title":"Infez Med"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"121614","DOI":"10.1016\/j.lfs.2023.121614","article-title":"Gut-liver axis in the progression of nonalcoholic fatty liver disease:From the microbial derivatives-centered perspective","volume":"321","author":"Luo","year":"2023","journal-title":"Life Sci"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease:Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"2110194","DOI":"10.1080\/20002297.2022.2110194","article-title":"Dysbiotic human oral microbiota alters systemic metabolism via modulation of gut microbiota in germ free mice","volume":"14","author":"Yamazaki","year":"2022","journal-title":"J Oral Microbiol"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2017.05.008","article-title":"Understanding the holobiont:How microbial metabolites affect human health and shape the immune system","volume":"26","author":"Postler","year":"2017","journal-title":"Cell Metab"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"e0136921","DOI":"10.1128\/Spectrum.01369-21","article-title":"The short-chain fatty acids propionate and butyrate augment adherent-invasive Escherichia coli virulence but repress inflammation in a human intestinal enteroid model of infection","volume":"9","author":"Pace","year":"2021","journal-title":"Microbiol Spectr"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/gutjnl-2018-316307","article-title":"Small metabolites, possible big changes:A microbiota-centered view of non-alcoholic fatty liver disease","volume":"68","author":"Chu","year":"2019","journal-title":"Gut"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"e2116125118","DOI":"10.1073\/pnas.2116125118","article-title":"Local acetate inhibits brown adipose tissue function","volume":"118","author":"Sun","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"G900","DOI":"10.1152\/ajpgi.00265.2013","article-title":"Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids","volume":"305","author":"den Besten","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"E272","DOI":"10.1152\/ajpendo.00053.2012","article-title":"Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice","volume":"303","author":"Vinolo","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12876-020-01194-2","article-title":"Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Takai","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1017\/S0007114515003621","article-title":"Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)","volume":"114","author":"Jin","year":"2015","journal-title":"Br J Nutr"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1038\/s41598-017-06447-x","article-title":"Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice","volume":"7","author":"Weitkunat","year":"2017","journal-title":"Sci Rep"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"e2200597","DOI":"10.1002\/mnfr.202200597","article-title":"Butyrate attenuates hepatic steatosis induced by a high-fat and fiber-deficient diet via the hepatic GPR41\/43-CaMKII\/HDAC1-CREB pathway","volume":"67","author":"Zheng","year":"2023","journal-title":"Mol Nutr Food Res"},{"key":"R40-20240828","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fphar.2018.00533","article-title":"The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor a-stimulated endothelial cells via activation of GPR41\/43 and inhibition of HDACs","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.3390\/nu14245355","article-title":"Precision nutrition in NAFLD:Effects of a high-fiber intervention on the serum metabolome of NAFD patients-a pilot study","volume":"14","author":"Stachowska","year":"2022","journal-title":"Nutrients"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease","volume":"6","author":"Rau","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/nu11010051","article-title":"Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors","volume":"11","author":"de la Cuesta-Zuluaga","year":"2018","journal-title":"Nutrients"},{"key":"R44-20240828","doi-asserted-by":"crossref","first-page":"12515","DOI":"10.1038\/s41598-019-48775-0","article-title":"Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans","volume":"9","author":"M\u00fcller","year":"2019","journal-title":"Sci Rep"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","article-title":"The continuing importance of bile acids in liver and intestinal disease","volume":"159","author":"Hofmann","year":"1999","journal-title":"Arch Intern Med"},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.7150\/ijbs.44774","article-title":"Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of lipid metabolism","volume":"16","author":"Kumari","year":"2020","journal-title":"Int J Biol Sci"},{"key":"R47-20240828","doi-asserted-by":"crossref","first-page":"154457","DOI":"10.1016\/j.metabol.2020.154457","article-title":"Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression","volume":"116","author":"Nimer","year":"2021","journal-title":"Metabolism"},{"key":"R48-20240828","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"R49-20240828","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"R50-20240828","doi-asserted-by":"crossref","first-page":"e03263","DOI":"10.1128\/mBio.03263-19","article-title":"Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease","volume":"11","author":"Fei","year":"2020","journal-title":"mBio"},{"key":"R51-20240828","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.2147\/DMSO.S249949","article-title":"Serum LPS and CD163 biomarkers confirming the role of gut dysbiosis in overweight patients with NASH","volume":"13","author":"Hegazy","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R52-20240828","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/nu12030699","article-title":"Adipokines and endotoxemia correlate with hepatic steatosis in non-alcoholic fatty liver disease (NAFLD)","volume":"12","author":"Nier","year":"2020","journal-title":"Nutrients"},{"key":"R53-20240828","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.24552","article-title":"Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"R54-20240828","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.3390\/nu14214467","article-title":"Preventive mechanism of lycopene on intestinal toxicity caused by cyclophosphamide chemotherapy in mice by regulating TLR4-MyD88\/TRIF-TRAF6 signaling pathway and gut-liver axis","volume":"14","author":"Pan","year":"2022","journal-title":"Nutrients"},{"key":"R55-20240828","first-page":"875","article-title":"Circulating microbiota-derived metabolites:A \u201cliquid biopsy?Int J Obes (Lond)","volume":"44","author":"Aragon\u00e8s","year":"2020"},{"key":"R56-20240828","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J Hepatol"},{"key":"R57-20240828","doi-asserted-by":"crossref","first-page":"104009","DOI":"10.1016\/j.micpath.2020.104009","article-title":"Contribution of endotoxin to Th17 bias in patients with non-alcoholic steatohepatitis","volume":"142","author":"Wang","year":"2020","journal-title":"Microb Pathog"},{"key":"R58-20240828","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1080\/10408398.2021.1966738","article-title":"Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD):focusing on the gut-liver axis","volume":"63","author":"Han","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R59-20240828","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/metabo12010064","article-title":"Unlike glycerophosphocholine or choline chloride, dietary phosphatidylcholine does not increase plasma trimethylamine-N-oxide levels in Sprague-Dawley rats","volume":"12","author":"Shirouchi","year":"2022","journal-title":"Metabolites"},{"key":"R60-20240828","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/19390211.2019.1639875","article-title":"Choline:The neurocognitive essential nutrient of interest to obstetricians and gynecologists","volume":"17","author":"Wallace","year":"2020","journal-title":"J Diet Suppl"},{"key":"R61-20240828","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nutres.2022.02.004","article-title":"Lower plasma glutathione, choline, and betaine concentrations are associated with fatty liver in postmenopausal women","volume":"101","author":"Muzsik-Kazimierska","year":"2022","journal-title":"Nutr Res"},{"key":"R62-20240828","doi-asserted-by":"crossref","first-page":"G634","DOI":"10.1152\/ajpgi.00249.2009","article-title":"Betaine improved adipose tissue function in mice fed a high-fat diet:A mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease","volume":"298","author":"Wang","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R63-20240828","first-page":"1399","article-title":"Choline deficiency:A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation","volume":"22","author":"Buchman","year":"1995","journal-title":"Hepatology"},{"key":"R64-20240828","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0004-28032011000100015","article-title":"Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis","volume":"48","author":"Marcolin","year":"2011","journal-title":"Arq Gastroenterol"},{"key":"R65-20240828","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1017\/S1431927620024265","article-title":"Effect of betaine supplementation on liver tissue and ultrastructural changes in methionine-choline-deficient diet-induced NAFLD","volume":"26","author":"Veskovi\u0107","year":"2020","journal-title":"Microsc Microanal"},{"key":"R66-20240828","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/liv.13249","article-title":"Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency","volume":"37","author":"Sookoian","year":"2017","journal-title":"Liver Int"},{"key":"R67-20240828","doi-asserted-by":"crossref","first-page":"101183","DOI":"10.1016\/j.diabet.2020.07.010","article-title":"Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes","volume":"47","author":"Le\u00f3n-Mimila","year":"2021","journal-title":"Diabetes Metab"},{"key":"R68-20240828","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1872-034X.2012.00976.x","article-title":"Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis:A multi-center validation study","volume":"42","author":"Imajo","year":"2012","journal-title":"Hepatol Res"},{"key":"R69-20240828","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"R70-20240828","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13668-018-0252-z","article-title":"Trimethylamine N-oxide and risk of cardiovascular disease and mortality","volume":"7","author":"Kanitsoraphan","year":"2018","journal-title":"Curr Nutr Rep"},{"key":"R71-20240828","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/metabo12121243","article-title":"Trimethylamine N-oxide levels in non-alcoholic fatty liver disease:A systematic review and meta-analysis","volume":"12","author":"Theofilis","year":"2022","journal-title":"Metabolites"},{"key":"R72-20240828","doi-asserted-by":"crossref","first-page":"e1900257","DOI":"10.1002\/mnfr.201900257","article-title":"Trimethylamine N-oxide aggravates liver steatosis through modulation of bile acid metabolism and inhibition of farnesoid X receptor signaling in nonalcoholic fatty liver disease","volume":"63","author":"Tan","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"R73-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.01.060","article-title":"Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine","volume":"594","author":"Shi","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"R74-20240828","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3390\/nu10121971","article-title":"Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome","volume":"10","author":"Barrea","year":"2018","journal-title":"Nutrients"},{"key":"R75-20240828","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jbiosc.2014.03.001","article-title":"Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet","volume":"118","author":"Gao","year":"2014","journal-title":"J Biosci Bioeng"},{"key":"R76-20240828","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.3748\/wjg.v25.i20.2450","article-title":"Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats","volume":"25","author":"Zhao","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R77-20240828","doi-asserted-by":"crossref","first-page":"567654","DOI":"10.3389\/fmicb.2020.567654","article-title":"Microbial metabolites:Critical regulators in NAFLD","volume":"11","author":"Dai","year":"2020","journal-title":"Front Microbiol"},{"key":"R78-20240828","doi-asserted-by":"crossref","first-page":"fj201800544","DOI":"10.1096\/fj.201800544","article-title":"The gut microbiota metabolite indole alleviates liver inflammation in mice","volume":"32","author":"Beaumont","year":"2018","journal-title":"FASEB J"},{"key":"R79-20240828","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/jn\/nxab032","article-title":"Hepatoprotective effects of indole, a gut microbial metabolite, in leptin-deficient obese mice","volume":"151","author":"Knudsen","year":"2021","journal-title":"J Nutr"},{"key":"R80-20240828","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.31115","article-title":"Indole alleviates diet-induced hepatic steatosis and inflammation in a manner involving myeloid cell 6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3","volume":"72","author":"Ma","year":"2020","journal-title":"Hepatology"},{"key":"R81-20240828","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/j.celrep.2019.08.080","article-title":"Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"28","author":"Krishnan","year":"2019","journal-title":"Cell Rep"},{"key":"R82-20240828","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.3390\/nu11092062","article-title":"Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"key":"R83-20240828","doi-asserted-by":"crossref","first-page":"110442","DOI":"10.1016\/j.cellsig.2022.110442","article-title":"Indole-3-acetic acid improves the hepatic mitochondrial respiration defects by PGC1a up-regulation","volume":"99","author":"Zhang","year":"2022","journal-title":"Cell Signal"},{"key":"R84-20240828","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1007\/s11695-021-05321-0","article-title":"Role of indole-3-acetic acid in NAFLD amelioration after sleeve gastrectomy","volume":"31","author":"Wang","year":"2021","journal-title":"Obes Surg"},{"key":"R85-20240828","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.3390\/nu13103509","article-title":"Indole-3-propionic acid, a gut-derived tryptophan metabolite, associates with hepatic fibrosis","volume":"13","author":"Sehgal","year":"2021","journal-title":"Nutrients"},{"key":"R86-20240828","first-page":"1","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp Mol Med"},{"key":"R87-20240828","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1021\/acs.jafc.0c05205","article-title":"Indole-3-propionic acid improved the intestinal barrier by enhancing epithelial barrier and mucus barrier","volume":"69","author":"Li","year":"2021","journal-title":"J Agric Food Chem"},{"key":"R88-20240828","first-page":"917","article-title":"Indole-3-propionic acid-aggravated CCl (4)-induced liver fibrosis via the TGF-b1\/Smads signaling pathway","volume":"9","author":"Liu","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"R89-20240828","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/gfs133","article-title":"p-cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells","volume":"28","author":"Sun","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R90-20240828","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/toxins10090367","article-title":"Impacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120","volume":"10","author":"Liu","year":"2018","journal-title":"Toxins (Basel)"},{"key":"R91-20240828","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/toxins10100384","article-title":"The impact of uremic toxicity induced inflammatory response on the cardiovascular burden in chronic kidney disease","volume":"10","author":"Claro","year":"2018","journal-title":"Toxins (Basel)"},{"key":"R92-20240828","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41430-018-0386-5","article-title":"A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease:A randomized, double-blind, placebo-controlled trial","volume":"73","author":"Chashmniam","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"R93-20240828","doi-asserted-by":"crossref","first-page":"e01188","DOI":"10.1128\/mBio.01188-18","article-title":"Branching out:Alterations in bacterial physiology and virulence due to branched-chain amino acid deprivation","volume":"9","author":"Kaiser","year":"2018","journal-title":"mBio"},{"key":"R94-20240828","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","article-title":"Emerging roles for branched-chain amino acid metabolism in cancer","volume":"37","author":"Sivanand","year":"2020","journal-title":"Cancer Cell"},{"key":"R95-20240828","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","article-title":"mTORC1 signaling and the metabolic control of cell growth","volume":"45","author":"Ben-Sahra","year":"2017","journal-title":"Curr Opin Cell Biol"},{"key":"R96-20240828","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ijms19040954","article-title":"Branched chain amino acids:beyond nutrition metabolism","volume":"19","author":"Nie","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R97-20240828","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.aav0558","article-title":"Branched-chain amino acids in disease","volume":"363","author":"White","year":"2019","journal-title":"Science"},{"key":"R98-20240828","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab"},{"key":"R99-20240828","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41569-022-00760-3","article-title":"Branched-chain amino acids in cardiovascular disease","volume":"20","author":"McGarrah","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"R100-20240828","doi-asserted-by":"crossref","first-page":"101261","DOI":"10.1016\/j.molmet.2021.101261","article-title":"Insulin action, type 2 diabetes, and branched-chain amino acids:A two-way street","volume":"52","author":"White","year":"2021","journal-title":"Mol Metab"},{"key":"R101-20240828","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3390\/biomedicines10061444","article-title":"The emerging role of branched chain amino acids in liver diseases","volume":"10","author":"Lo","year":"2022","journal-title":"Biomedicines"},{"key":"R102-20240828","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbapap.2009.10.004","article-title":"The logic of the hepatic methionine metabolic cycle","volume":"1804","author":"Martinov","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R103-20240828","doi-asserted-by":"crossref","first-page":"1065668","DOI":"10.3389\/fmicb.2022.1065668","article-title":"Gut microbiota contributes to the methionine metabolism in host","volume":"13","author":"Wu","year":"2022","journal-title":"Front Microbiol"},{"key":"R104-20240828","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1039\/C9FO00766K","article-title":"Dietary methionine restriction improves the gut microbiota and reduces intestinal permeability and inflammation in high-fat-fed mice","volume":"10","author":"Yang","year":"2019","journal-title":"Food Funct"},{"key":"R105-20240828","doi-asserted-by":"crossref","first-page":"e0234422","DOI":"10.1128\/spectrum.02344-22","article-title":"Gut microbial genes and metabolism for methionine and branched-chain amino acids in diabetic nephropathy","volume":"11","author":"Kim","year":"2023","journal-title":"Microbiol Spectr"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_122_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:12:42Z","timestamp":1787166762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_122_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_122_23","relation":{},"ISSN":["1016-3190","2223-8956"],"issn-type":[{"value":"1016-3190","type":"print"},{"value":"2223-8956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"2023-05-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}